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Abstract
Background
Leprosy is a major public health problem in many low and middle income countries, espe-
cially in India, and contributes considerably to the global burden of the disease. Leprosy and
poverty are closely associated, and therefore the economic burden of leprosy is a concern.
However, evidence on patient’s expenditure is scarce. In this study, we estimate the expen-
diture in primary care (outpatient) by leprosy households in two different public health
settings.
Methodology/Principal findings
We performed a cross-sectional study, comparing the Union Territory of Dadra and Nagar
Haveli with the Umbergaon block of Valsad, Gujrat, India. A household (HH) survey was
conducted between May and October, 2016. We calculated direct and indirect expenditure
by zero inflated negative binomial and negative binomial regression. The sampled house-
holds were comparable on socioeconomic indicators. The mean direct expenditure was
USD 6.5 (95% CI: 2.4–17.9) in Dadra and Nagar Haveli and USD 5.4 (95% CI: 3.8–7.9) per
visit in Umbergaon. The mean indirect expenditure was USD 8.7 (95% CI: 7.2–10.6) in
Dadra and Nagar Haveli and USD 12.4 (95% CI: 7.0–21.9) in Umbergaon. The age of the
leprosy patients and type of health facilities were the major predictors of total expenditure on
leprosy primary care. The higher the age, the higher the expenditure at both sites. The pri-
vate facilities are more expensive than the government facilities at both sites. If the public
health system is enhanced, government facilities are the first preference for patients.
Conclusions/Significance
An enhanced public health system reduces the patient’s expenditure and improves the
health seeking behaviour. We recommend investing in health system strengthening to
reduce the economic burden of leprosy.
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Author summary
Leprosy leads to low quality of life even after cure. The anaesthetic hands and feet leading
to ulcers and deformities, stigma and poor mental health are just a few challenges. After
declaration of leprosy elimination at global level, the research activities reduced signifi-
cantly, and the health economics aspect was not an exception. The knowledge on eco-
nomic burden of a disease helps in prioritization, policy making and advocacy. Our study
is a step towards quantifying the economic burden of leprosy. Currently the aim is to elim-
inate leprosy at national level, therefore the countries need more information to plan high
impact activities. Moreover, the patient’s perspective is important as they are the end-
point recipients. Our study explores the patient’s financial burden due to leprosy (outpa-
tient services), which is a significant indicator of a public health program’s success. If
invested properly, the public health system has potential to reduce the economic burden
of public health diseases. Our study is an attempt to link the patient’s perspective with the
health system performance. This will help to encourage health systems strengthening.
Introduction
Leprosy is caused by Mycobacterium leprae, affecting the peripheral skin, nerve and nasal
mucosa [1]. The adverse impact of leprosy on human lives is serious due to nerve function
impairment and disabilities. Moreover, the early manifestation of disability in the form of sen-
sory loss of hands or feet, often fails to seize attention of clinicians and patients, resulting into
detection delay and further transmission of M. leprae [2, 3]. Therefore, the annual new case
detection rate (NCDR) of leprosy is stagnant since many years [4]. The expectation to perma-
nently eradicate leprosy, also referred as zero transmission [5] is now reflected into new WHO
targets i.e. zero grade 2 disabilities among children, and new cases with grade 2 disability <1
case/million population [6]. However, the targets are difficult to achieve in the near future [7,
8], which means that leprosy will keep on imposing burden in many endemic countries.
Leprosy and poor socioeconomic status are in a vicious cycle, characterized by inequality
[9–11], poor education [12], poverty [13, 14], stigma, etc. [15, 16]. A broad spectrum of evi-
dence confirms the strength of the relationship between leprosy and poverty [17–21]. Evidence
from Bangladesh shows that leprosy affected households have a poor nutritional level due to
lower food expenditure per capita and household food stocks. This in fact increases the risk of
acquiring leprosy in healthy household members [22]. Another study revealed that “people
affected by leprosy are less likely to be stigmatized because of leprosy impairments than for
their incapacity to contribute to family/community finances” [23]. Furthermore, leprosy inci-
dence is high in the productive age group, resulting in long term financial loss [17]. Therefore,
we suspect that the economic burden of leprosy is higher than perceived so far.
Household expenditure represents the patient’s perspective and is critical in estimating the
economic burden. It is now routinely done across diseases [24], revealing underlying expendi-
ture like income loss, which can sometimes be significant. Unfortunately, the cost evidence in
leprosy is limited [25]. A literature search on PubMed using a broad search builder with ‘lep-
rosy’ as MeSH term and ‘economics’ as sub-MeSH heading (year 2001 onwards), resulted in
51 records. Only 6 records presented some cost estimates: three studies focused on a particular
event (ENL reaction and ulceration) in hospital settings [26–28]; two cost-effectiveness analy-
sis (CEA) studies on provider’s perspective [29, 30]; and one study on human resource cost of
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a project [31]. No study was found exclusively on primary care in a general public health set-
ting, covering the patient’s perspective.
Leprosy is a chronic infectious disease with long treatment duration, therefore needs long
term care and support, mainly in an outpatient setting. Therefore, the primary objective of our
study is to estimate the expenditure in primary (outpatient) care incurred by leprosy patients
in two different health system settings in India. The secondary objective is to compare the
effect of the health systems on consumer behaviour and practices. The results will help in
understanding the economic burden of leprosy in primary care, and eventually contribute in
building an investment case for leprosy elimination [25].
Methods
Ethics statement
The study was conducted under the Leprosy Post Exposure Prophylaxis (LPEP) program,
approved in India by the Institutional Human Ethics Committees of the National Institute of
Epidemiology (NIE/IHEC201407-01). Written informed consent was received from the
respondents and necessary permission was taken from the concerned departments.
Background of LPEP in India
India contributes almost 60% to the global leprosy burden [4]. The LPEP program was
launched in March 2015 in the Union Territory of Dadra and Nagar Haveli (DNH), located on
the western coast of India. The program aims to assess impact and feasibility of contact tracing
and administration of single dose of rifampicin (SDR) to asymptomatic contacts of leprosy
cases. LPEP is implemented by the National Leprosy Elimination Program (NLEP) of India
[32].
Study design
The study followed a cross-sectional design, where a cohort from the Union Territory of DNH
was compared with a cohort from Umbergaon block of Valsad district, Gujarat, India. A
union territory is an administrative division, ruled directly by the federal government, whereas
a block is the smallest administrative unit under a district. The cohorts were leprosy cases
detected between April 2015 and March, 2016. A sample of 120 participants from each group
was selected randomly from the annual leprosy case detection list. In the financial year of
2015–16, DNH reported 425 and Umbergaon reported 287 cases.
Study sites
DNH and Umbergaon share boundaries and are comparable with regard to demographic, epi-
demiological, and socioeconomic indicators (Table 1), but not to public health facilities due to
the different governmental arrangement (see below).
Both study sites are mainly tribal areas, but there is a remarkable difference in the public
health system of both sites. The public health system in DNH is enhanced because it falls
directly under the federal government by bypassing provincial bureaucracy, and receives a
higher health budget per capita [33–35] than the provinces. In comparison to DNH, Umber-
gaon has more PHCs per population covered; the average population screened for leprosy by a
Primary Health Center (PHC) in Umbergaon was 43% more than DNH PHC (Table 1). The
actual screening (active and passive) coverage was reported to be very high in both sites,
approximating the total population of these areas. In the year 2015–16, the leprosy program
performed two active case detection surveys in both sites. Currently both sites fall under the
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Leprosy Case Detection Campaign (LCDC), which was launched in early 2016 under the
NLEP [36]. Furthermore, the population screened by Umbergaon PHCs is far more than the
public health norms for tribal PHCs, i.e. 86% more in Umbergaon and 26% in DNH [37]. Typ-
ically, a PHC should cover a population of 20,000 in hilly, tribal, or difficult areas and 30,000
populations in plain areas [37]. Both sites provide free of charge leprosy outpatient department
(OPD) services at all public health facilities, but the health systems vary with regard to infra-
structure, availability, accessibility, and quality of services.
Data collection and analysis
A household survey was conducted between June and October, 2016 by means of a structured
questionnaire. The data were collected by two experienced staff members, post-graduates in
public health. The patient, or head of the household, or most knowledgeable person in the
household was asked to report on patient demographics, HH socioeconomic status, accessibil-
ity of health services, treatment seeking history and OPD expenditure. Respondents were
asked to report on the last three OPD visits, either in a public or private facility, in the last 6
months. The database was created in Excel. The analysis included only those patients who
mentioned at least 1 OPD visit out of 3.
Table 1. Comparison of Dadra and Nagar Haveli and Umbergaon with regard to demography, epidemiology,
socioeconomics factors, and public health facilities.
Indicators DNH Umbergaon
Demographic & Socioeconomic indicators (Census 2011)
Number of households (HH) 76,121 54,814
Population 343,709 261,204
Rural population 53.27% 68.74%
Females (per 1000 males) 774 933
Literacy 76.24% 69.53%
Schedule tribes# 51.95% 51.32%
Total working population 45.73% 40.40%
Epidemiology (2015–16)
Leprosy screened population 388,613 371,731
New cases detected 425 287
NCDR (per 100,000 per year) 109.36 77.21
New child cases (age < 15 years) 23.29% 16.03%
New female cases 57.88% 61.67%
Prevalence rate (per 10,000 per year) 6.77 3.81
Grade II disability in new cases 3.3% 2.44%
PB/MB ratio 2.76 3.15
Public Health Infrastructure (2015–16)
Area (sq. km) 491 343
Primary health centres (PHC) 15 10
Sub-centres 50 64
Average population screened for leprosy by health centre 25,907 37,173
#The Scheduled Castes (SCs) and Scheduled Tribes (STs) are various officially designated groups of historically
disadvantaged indigenous people in India.
 NCDR: new case detection rate
 PB: Paucibacillary; MB: Multibacillary
https://doi.org/10.1371/journal.pntd.0006181.t001
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The costs were categorized as direct and indirect expenditure. The direct part included the
expenditure on consultation, investigations and medicines & supplies. The indirect part consti-
tuted expenditure on transport, food, and days lost during illness of the patient and attendant.
We calculated the transportation expenditure by multiplying to-and-fro distance from house to
the nearest health facility, using the government transportation rate [38]. The wage loss was
analysed by means of the human capital approach [39]. The wage losses for patients and atten-
dants per illness episode were calculated by using government minimum wage rates [40]. There
were 20 (8%) patients who paid at least 1 OPD visit, but failed to report any loss of productive
days. For these, we imputed half a day wage loss per visit under the assumption that at least half
a day (4 hours) is required to travel and avail services for each illness episode. But attendant’s
productive day loss could be zero, as not all patients required attendants. We reported separately
the days lost by child patients (age< 16 years) as ‘school days lost’, but while calculating indirect
expenditure, all patients and attendants were assumed to be 16 years and older. The results are
presented in US dollars (USD) using the conversion rate of INR 67 for 1 dollar for the year 2016
[41]. The analyzed expenditure was exclusively of outpatient services.
Data modelling
In order to answer our objectives, i.e. expenditure and patient’s health seeking behaviour differ-
ences in DNH and Umbergaon, we used an integrated analytical approach. The data distribu-
tion was evaluated by observing normality plots. The distribution of the direct expenditure
variables were not normally distributed due to abundance of zeros and highly skewed for non-
zero values, which is common in cost data [42]. The indirect expenditure variables were skewed,
but not zero inflated. We compared four different distribution models, i.e. Poisson, negative
binomial, zero inflated Poisson, and zero inflated negative binomial distribution [43]. The ‘zero
inflated negative binomial regression’ was selected for direct expenditure variables, and ‘nega-
tive binomial regression’ for indirect and total expenditure variables. We estimated the mean
expenditure for each variable, followed by association measurement between expenditure and
patient’s household characteristics. Only significant (p<0.05) variables were modelled together
for multivariate regression analysis (Generalized Linear Model). The magnitude of total expen-
diture was compared against the individual’s monthly income. The total per visit expenditure
was defined catastrophic for an individual, if it exceeded 10% of the quarterly income [44, 45].
We assumed that at least one visit to the health centre in a quarter is necessary for regular
check-up of leprosy. However as per NLEP norms, patients should visit the health center every
month, which rarely happens. In practice, monthly MDT is delivered by staff at the patient’s
doorstep and health facility visits occur only during severe illnesses to avoid any wage loss.
Results
A total of 240 patient households (120 in each group) were approached to capture their charac-
teristics and OPD visit details in the last 6 months. The area-wise household characteristics are
summarized in Table 2. The mean age (DNH: 25, Umbergaon: 24) showed a young and com-
parable population in both sites. The average monthly income (DNH: USD 81, Umbergaon:
USD 97), expenditure (DNH: USD 73, Umbergaon: USD 83) and saving (DNH: USD 1
Umbergaon: USD 1) per earning member showed a poor economic status in both sites. The
respondents differed prominently on characteristics such as distance to the nearest health facil-
ity, type of housing, OPD frequency and type of facility visited. Paucibacillary (PB) leprosy was
more prevalent in both sites than multibacillary (MB) leprosy. Collectively in the three visits,
69% of the respondents in Umbergaon and 14% of the respondents in DNH had not paid any
visit, and were therefore dropped for further analysis.
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The three visits expenditure was aggregated to obtain an average per visit. The details of
direct and indirect expenditure are shown in Table 3. DNH and Umbergaon were comparable
on demographic and socioeconomic parameters, however, they statistically significantly dif-
fered with regard to health seeking behaviour. As a behaviour, OPD visit frequency is higher,
and a government facility is more preferred in DNH as compared to Umbergaon.
All the presented expenditure estimates are per visit. The mean consultation fee in DNH
and Umbergaon was comparable (DNH: USD 1.2, Umbergaon: USD 1.6). The mean expendi-
ture on medicines and supplies (USD 7) was 80% higher in DNH than Umbergaon (USD 4).
Only 2 respondents reported investigation expenditure in Umbergaon and none in DNH.
Only 1 respondent in Umbergaon and 2 respondents in DNH reported expenditure on food.
The mean medical direct expenditure per visit (DNH: USD 6.5, Umbergaon: USD 5.4) was not
statistically significantly different between the sites. In indirect expenditure, the mean wage
loss for patients was the highest item (DNH: USD 5.2, Umbergaon: USD 7.3), followed by
attendant wage loss (DNH: USD 2.7, Umbergaon: USD 3.7). Transportation expenditure
(DNH: USD 0.8, Umbergaon: USD 1.4) differed significantly (p 0.01) in the two groups.
The details on association of expenditures with patient’s household characteristics are
shown in Table 4. The proportion of patients with catastrophic expenditure in DNH was 88%
less than in Umbergaon. If catastrophic expenditure occurred, then direct expenditure rose
three-fold in DNH and two-fold in Umbergaon, (DNH: coef. 2.92, 95% CI: 1.86–3.98; Umber-
gaon: coef. 1.00, 95% CI: 0.23–1.77). In DNH, the direct expenditure decreased statistically
Table 2. Socioeconomic characteristics of patient households in DNH and Umbergaon.
DNH (N = 120) Umbergaon (N = 120) p
Mean (USD) 95% CI Mean (USD) 95% CI
Age (years) 24.7 22.0–27.7 23.6 17.9–31.1 0.58
HH size 6.0 5.6–6.4 5.4 4.7–6.3 0.03
Number of earning members 1.5 1.3–1.7 1.6 1.1–2.3 0.41
Monthly income per earning member in HH in INR 5,456 (81) 5,144–5,787 6,503 (97) 5,642–7,495 0.00
Monthly expenditure per earning member in HH in INR 4,890 (73) 4,566–5,238 5,591 (83) 4,736–6,601 0.01
Monthly savings per earning member in HH in INR 74 (1) 41–133 87 (1) 47–161 0.71
Distance of nearest health facility (km) 5.1 4.6–5.6 9 8.0–9.9 0.00
N % N % p
Sex: Female 73 60.8 70 58.3 0.69
Occupation: Not Earning 87 72.5 67 55.8 0.01
Leprosy type: PB 104 86.7 92 76.7 0.05
Type of housing: Concrete predominant 95 79.2 68 56.7 0.00
OPD frequency (Max 3. duration last 6 months)
0 17 14.2 83 69.2 0.00
1 77 64.2 25 20.8
2 24 20.0 11 9.2
3 2 1.7 1 0.8
Type of OPD facility (last 3 visits in 6 months)
No visit 17 14.2 83 69.2
Only government 97 80.8 14 11.7 0.00
Both 4 3.3 5 4.2
Only private 2 1.7 18 15.0
Not earning in comparison to earning, includes unemployed, children, housewives
 In comparison to mud predominant houses
https://doi.org/10.1371/journal.pntd.0006181.t002
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significantly more than two-fold (coef. -2.49, 95% CI: -3.74 to -1.24) with the increase in age
groups, whereas a decrease in indirect expenditure against age was not statistically significant
(coef. -0.40, 95% CI: -0.92 to 0.12). Umbergaon’s indirect expenditure decreased statistically
significantly more than half (coef. -0.79, 95% CI: -1.49 to -0.09) among patients who visited
both (government and private) facilities in comparison to those who visited only private facili-
ties. For total expenditure, age and type of facility remained statistically significant factors,
whereas catastrophic expenditure remained statistically significant only in DNH. Therefore
these factors were considered for the next level of analysis, i.e. multivariate regression.
Table 5 presents the association when only statistically significant variables (p< 0.05) are
modelled together with total expenditure (direct + indirect). When modelled separately for
both sites, all the variables in Umbergaon turned statistically not-significant. Age however,
remained a statistically significant factor (p = 0.03) in DNH. The overall model (Omnibus
Test) was statistically significant in DNH (p = 0.001), but not in Umbergaon (p = 0.06). Fur-
thermore, the same model was applied jointly for DNH and Umbergaon (n = 140), which was
overall highly significant (p 0.001). The age (p = 0.019) and type of facility (p = 0.002) were
statistically significant, but catastrophic expenditure became statistically not-significant. Cata-
strophic coefficients however, indicated that catastrophic expenditure groups (in both the
areas) had risk of spending (total expenditure) almost twice, compared to non-catastrophic
groups.
Discussion
Our study explored the leprosy patient’s financial burden due to primary care outpatient ser-
vices. Primary care is an important aspect of disease control under a public health program,
Table 3. Direct and indirect expenditure in INR by leprosy patients on outpatient care in DNH and Umbergaon.
DNH Umbergaon p
n reported % N = 0 Pr
N = 0
Mean
(USD)
95% CI n reported % N = 0 Pr
N = 0
Mean
(USD)
95% CI
OPD direct expenditure per visit
Consultation 103 89 0.90 78 (1.2) 36–171 37 38 0.36 107 (1.6) 81–143 0.22
Medicines & supplies 103 91 0.89 478 (7.1) 167–
1394
37 33 0.38 265
(4)
185–380 0.10
Total medical direct exp. 103 89 0.88 433 (6.5) 158–
1200
37 33 0.35 365 (5.4) 252–528 0.60
Transport (non-medical direct) 103 0 54 (0.8) 45–66 37 0 94
(1.4)
53–166 0.005
OPD indirect expenditure per visit (wage loss per illness episode)
Patient’s wage loss (age>15) 77 0 264 (3.9) 211–330 25 0 306 (4.6) 156–601 0.53
School days lost (Age<16) 26 0 2 1–3 12 25 3 1–10 0.38
Patient’s wage loss (assumed all adults) 103 0 346 (5.2) 285–420 37 0 489 (7.3) 277–864 0.07
Attendant’s wage loss 103 32 183 (2.7) 151–223 37 19 246 (3.7) 139–436 0.13
Indirect exp.+ Transport (assumed all
adult)
103 0 583 (8.7) 481–708 37 0 829 (12.4) 469–
1464
0.07
Total (direct+ indirect) exp. (assumed all
adults)
103 0 634 (9.5) 523–769 37 0 1075 (16) 609–
1901
0.006
 Pr N = 0: predicted probability of 0 expenditure
Medical direct expenditure (exp.) estimates are derived by zero inflated negative binomial regression.
Non-medical direct, Indirect and Total exp. estimates are derived by negative binomial regression.
Investigations and food were reported negligible, therefore, not included in the table.
https://doi.org/10.1371/journal.pntd.0006181.t003
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therefore costs at this level are important for policy and planning. Moreover, a high out of
pocket expenditure indicates public health systems inefficiency, and act as barrier to access ser-
vices [46]. The results show that the sampled patients were mainly in their economically pro-
ductive lifetime, indicating leprosy imposing a high economic burden. The leprosy patients of
DNH went more frequently to the OPD, and preferred a government facility as compared to
Umbergaon. Furthermore, the total expenditure (direct + indirect) was statistically signifi-
cantly lower in DNH than Umbergaon. The age of the leprosy patients and type of health
facilities were the major predictors of total expenditure. The higher the age, the higher the
expenditure, and private health facilities were more expensive than government facilities, at
both sites.
Table 4. Socioeconomic factors associated with expenditures by leprosy patients on outpatient services in DNH and Umbergaon (bivariate analyses).
DNH Umbergaon
Direct Indirect Total Direct Indirect Total
Coef. 95%
CI
P Coef. 95%
CI
p Coef. 95%
CI
P Coef. 95%
CI
p Coef. 95%
CI
p Coef. 95%
CI
p
Age < = 18 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
19–35 -2.29 -3.66
-0.93
.001 -0.56 -1.00
-0.12
.01 -0.68 -1.12
-0.25
.002 0.01 -0.52
0.54
.97 -0.75 -1.52
0.02
.06 -0.87 -1.64
-0.10
.03
> = 36 -2.49 -3.74
-1.24
.000 -0.40 -0.92
0.12
.13 -0.52 -1.04
0.00
.048 -0.23 -0.90
0.45
.51 -0.53 -1.33
0.28
.20 -0.47 -1.27
0.33
.25
Sex Male 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
Female -0.43 -2.02
1.15
.59 -0.11 -0.50
0.29
.60 -0.14 -0.54
0.25
.48 -0.32 -0.80
0.14
.17 -0.26 -0.97
0.44
.47 -0.39 -1.09
0.32
.28
Occupation Earning 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
Not Earning 2.09 0.13
4.05
.04 0.29 -0.14
0.71
.18 0.38 -0.04
0.81
.08 0.39 -0.09
0.89
.11 0.13 -0.60
0.85
.74 0.13 -0.59
0.86
.72
Income < = 5820 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
>5820 -0.28 -1.88
1.31
.73 0.20 -0.19
0.59
.31 0.17 -0.23
0.56
.41 0.32 -0.25
0.91
.27 0.33 -0.49
1.15
.43 0.31 -0.51
1.14
.46
Type leprosy PB 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
MB 1.32 -0.66
3.32
.19 0.25 -0.47
0.97
.50 0.52 -0.20
1.24
.16 0.12 -0.47
0.72
.68 -0.27 -1.09
0.56
.53 -0.15 -0.97
0.68
.73
Distance to nearest
facility
< = 6 km 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
>6 km -1.49 -3.25
0.27
.10 -0.15 -0.63
0.33
.53 -0.22 -0.70
0.27
.38 -.44 -0.89
0.01
.06 -0.43 -1.07
0.22
.19 -0.47 -1.12
0.17
.15
Type of facility
visited
Private 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
Both -3.11 -3.64
-2.58
.000 -1.09 -2.49
0.31
.13 -1.89 -3.29
-0.48
.01 0.02 -0.62
0.66
.95 -0.79 -1.49
-0.09
.03 -1.04 -1.74
-0.35
.00
Government -2.81 -3.49
-2.13
.000 -0.94 -2.64
0.76
.28 -1.62 -3.31
0.08
.06 -0.91 -2.01
0.18
.10 -0.51 -1.50
0.48
.31 -0.35 -1.34
0.64
.49
OPD visits frequency 1 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
2 -2.44 -3.54
-1.35
.000 0.09 -1.32
1.49
.90 0.05 -1.36
1.45
.95 0.01 -0.47
0.50
.95 -0.26 -2.26
1.74
.80 -0.13 -2.13
1.87
.90
3 -2.67 -4.64
-0.70
.01 0.27 -0.19
0.73
0.25 0.21 -0.25
0.67
.38 -0.31 -1.55
0.91
.61 -0.02 -0.73
0.69
.96 0.11 -0.60
0.82
.77
HH size < = 5 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
>5 0.01 -1.57
1.59
.99 -0.29 -0.69
0.12
0.16 -0.30 -0.70
0.10
.14 0.11 -0.36
0.59
.63 -0.06 -0.73
0.60
.85 -0.12 -0.78
0.55
.73
Catastrophic exp. No 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref) 1. (Ref)
Yes 2.92 1.86
3.98
.000 0.77 -0.05
1.60
0.07 1.21 0.39
2.03
.00 1.00 0.23
1.77
.01 1.25 -0.18
2.68
.09 1.29 -0.13
2.72
.08
https://doi.org/10.1371/journal.pntd.0006181.t004
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As a limitation, our study only considered direct and indirect costs, however skin anesthesia
(a common phenomenon), neuropathic pain [47, 48], poor mental health [49] and stigma [49,
50] can be significant factors, which can elevate the total expenditure further. We could not
focus on these parameters under patient characteristics, and recommend to explore this in
detail in future. Next, the households belong to poor socioeconomic groups, which correlates
with other studies [9, 13, 22], but we drew the sample from government records, which often
caters mainly to poor. Also, adequate representation of patients who are diagnosed and treated
completely in private facilities cannot be ascertained. The relatively small sample size is also a
limitation of this study. The sample size turned out to be low (reduced power) because of high
zero visits, meaning that patients often did not visit the outpatient clinics according to the offi-
cial schedule. Moreover, to minimize recall bias, we only included the patients of the most
recent one year, which was a small cohort. Many patients were not traceable due to migration.
Furthermore, we computed catastrophic expenditure based on the income, rather than con-
sumption pattern, which is a more rigorous method. The study is cross-sectional and there is
no insight on how patients adapt over time. We recommend to repeat the survey after an
appropriate time gap. Also, OPD expenditure is not as high as hospitalization, therefore often
failed to be recalled. We do not reject the possibility of recall bias, but we further reduced this
by averaging the expenditure from last three visits. Although we have quantified health seeking
behaviour, this study does not identify the underlying reasons for these patterns, which would
further necessitate qualitative studies.
So far, sound evidence is lacking on the private sector uptake of leprosy cases, therefore we
compared the patient’s selection of health facilities for primary leprosy care. We observed that
the government is mostly preferred over private health facilities (government 80.8% vs. private
1.7%) in an enhanced health system (DNH). In a non-enhanced health system (Umbergaon)
however, private is equally preferred (private 15% vs. government 11.7%). Moreover, in a non-
enhanced health system (Umbergaon) patients have poor health seeking behaviour (zero OPD
visits in last 6 months: Umbergaon 69% vs. DNH 14%). Contrary to the high number of sub-
jects reporting zero visits, the predicted probability of zero direct medical expenditure
(Umbergaon 0.35 vs. DNH 0.88) is lower in Umbergaon, and vice versa in DNH. It means that
patients in Umbergaon avoid visiting any health facility, but if they visit then end up paying
more than in DNH, therefore out of pocket direct medical expenditure acts as a potential
Table 5. Socioeconomic factors associated with total expenditure by leprosy patients on outpatient services in DNH and Umbergaon (multivariate analysis).
Total expenditure
DNH (N = 103) Umbergaon (N = 37) DNH+ Umbergaon (N = 140)
Coef. Std Err. 95% CI p Coef. Std Err. 95% CI p Coef. Std Err. 95% CI p
Age < = 18 1. (Ref) 1. (Ref) 1. (Ref)
19–35 -0.31 0.27 -0.83
0.21
.25 0.06 0.49 -0.89
1.01
.91 -0.21 0.23 -0.66
0.23
.35
> = 36 -0.53 0.23 -0.98
-0.08
.02 -0.20 0.49 -1.16
0.76
.69 -0.47 0.20 -0.86
-0.08
.02
Type of facility visited Pvt. 1. (Ref) 1. (Ref) 1. (Ref)
Both -0.67 1.02 -2.68
1.33
.51 -0.20 0.55 -1.28
0.88
.72 -0.24 0.42 -1.06
0.58
.56
Gov. -1.08 0.88 -2.80
0.64
.22 -0.80 0.44 -1.67
0.07
.07 -0.80 0.26 -1.30
-0.29
.00
Catastrophic exp. No 1. (Ref) 1. (Ref) 1. (Ref)
Yes 0.58 0.51 -0.43
1.59
.26 0.97 0.77 -0.54
2.48
.21 0.73 0.39 -0.03
1.48
.06
https://doi.org/10.1371/journal.pntd.0006181.t005
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barrier to access leprosy health care. The indirect expenditure is the largest cost impoverishing
component for patients. Next, the indirect expenditure with transportation and total expendi-
ture in an enhanced health system (DNH) is lower than non-enhanced health system (Umber-
gaon). Usually, a high variation is expected in indirect expenditure and transportation,
because in many instances they are not paid out of pocket and are presumptive e.g. wage loss.
This can lead to over or under reporting. For example, many people use their own vehicle or
are supported by others, and often fail to report this. This in turn leads to unrealistic and non-
comparable estimates, which are of low utility for policy purposes. Therefore, we used standard
government labour market and transportation rates in both areas for comparable results,
which are appropriate for the sampled socioeconomic groups. Our study identifies the linkage
between socioeconomic factors and expenditure increase. The total expenditure peaked at the
19–35 age category, which correlates with the human capital approach, i.e. the productive age
group is more weighted than early or old age [39, 51]. Next, private health facilities are signifi-
cantly more expensive than government facilities, therefore one of the reasons for higher total
expenditure in Umbergaon than DNH.
We conclude that the condition of public health systems has a direct relationship with the
patient’s expenditure, and the better the public health system, the lesser the expenditure from
the leprosy patient’s pocket. Next, the condition of public health system has a major effect on
the patient’s health seeking behaviour, i.e. selection of health facility and services uptake. If a
health system is weak, then leprosy patients are forced to seek private health care, which is
more expensive and imposes a significant financial burden on the leprosy affected population,
proven to be catastrophic. If a public health system is enhanced, then patients prefer to avail
government health facility services. We recommend to invest in health system strengthening
to reduce the economic burden of leprosy.
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